Skip to main content

Table 6 Guideline evaluation activities

From: Twelve years of clinical practice guideline development, dissemination and evaluation in Canada (1994 to 2005)

Evaluation Activities

Year of development

n = 1360 guidelines

Change

 

1994–1999

n = 730

% of guidelines (95% CI)

2000–2005

n = 630

% of guidelines (95% CI)

%

Effectiveness of dissemination/implementation was formally evaluated

6.1 (4.4–7.8)

12.2 (9.53–14.8)

+6.1

Plan to evaluate dissemination/implementation in future

59.8 (55.7–63.9)

22.7 (18.8–26.7)

-37.1

Guideline impact on health outcomes was formally evaluated

5.1 (3.5–6.7)

23.8 (20.4–27.3)

+18.7

Plan to evaluate guideline impact on health outcomes in future

51.4 (47.3–55.6)

32.6 (28.3–37.1)

-18.8

Companion document available for consumers

21.3 (18.4–24.4)

28.4 (24.9–31.9)

+7.1

Intend to produce consumer version in future

24.3 (21.1–27.4)

14.3 (11.6–17.0)

-10